Tag: biomedical
-
NantHealth, TransMed Partner on Cancer Genomics
Two companies offering medical analytics aim to provide cancer specialists with individualized genomic analyses for their patients, and more access to clinical trials.
-
Start-Up Reprogramming Stem Cells to Treat Heart Failure
A new enterprise, spun-off from the Gladstone Institutes in San Francisco, plans to regenerate heart muscle from other cells to treat heart failure.
-
Trial to Test Radio Waves to Treat Alzheimer’s
A clinical trial is inviting individuals with Alzheimer’s disease to test a device that its designers claim can reverse cognitive impairment resulting from Alzheimer’s disease.
-
Many Health Apps Found Not Helping People in Need
Many mobile apps designed to help manage one’s health are not assisting people in most need of that help and often do not appropriately respond to information with dangerous consequences.
-
Ostrich Antibodies to Fight Resistant Infections
A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals.
-
High Leukemia Remissions Reported for Engineered T-Cells
First results from an international clinical trial of engineered immune system cells to treat leukemia in children show high rates of remission, but also many severe adverse effects.
-
Biotech to Earn Up to $1 Billion from Synthetic Peptides
A biotechnology enterprise designing synthetic peptides to treat a range of diseases could gain up to $1 billion or more in a licensing deal with the pharmaceutical company AstraZeneca.
-
Stem Cell Therapy Shows Early Results with Multiple Myeloma
First results from an early clinical trial show some patients with multiple myeloma receiving replacement blood-forming stem cells achieved at least a partial response and did not suffer severe adverse effects.
-
Room-Temperature Vaccine Storage Techniques Devised
Vaccines against viral diseases today need to be kept refrigerated to prevent spoilage, which raises costs and often prevents their widespread use in many developing regions. A team of materials scientists at Ecole polytechnique fédérale de Lausanne in Switzerland, or EPFL, proposes methods for storing vaccines without refrigeration for many days.
-
Company Launches to Discover Gut-Brain Therapies
A California Institute of Technology biologist is starting a new enterprise to discover treatments for neurological disorders through pathways originating in the gut.